No black box warning on record for Nivestym

As of the latest FDA labeling reviewed, Nivestym (FILGRASTIM-AAFI) does not carry a black box warning. Standard warnings and precautions still apply — see the full Nivestym medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Fatal splenic rupture: Evaluate patients who report left upper abdominal or shoulder pain for an enlarged spleen or splenic rupture. ( 5.1 ) • Acute respiratory distress syndrome (ARDS): Evaluate patients who develop fever and lung infiltrates or respiratory distress for ARDS. • Discontinue NIVESTYM in patients with ARDS. ( 5.2 ) • Serious allergic reactions, including

No black box warning on record for Nivestym

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Fatal splenic rupture: Evaluate patients who report left upper abdominal or shoulder pain for an enlarged spleen or splenic rupture. ( 5.1 ) • Acute respiratory distress syndrome (ARDS): Evaluate patients who develop fever and lung infiltrates or respiratory distress for ARDS. • Discontinue NIVESTYM in patients with ARDS. ( 5.2 ) • Serious allergic reactions, including

Nivestym Black Box Warning

No black box warning on record for Nivestym

Other warnings & precautions

Nivestym Black Box Warning

No black box warning on record for Nivestym

Other warnings & precautions